ORIGINAL RESEARCH
Accepted on 28 Feb 2025
Ribosomal protein L9 is a potential therapeutic target for B-ALL through the activation of the p53 signaling pathway
doi 10.3389/fimmu.2025.1560706
5,108
Total downloads
16k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
ORIGINAL RESEARCH
Accepted on 28 Feb 2025
CORRECTION
Published on 04 Feb 2025
ORIGINAL RESEARCH
Published on 03 Jan 2025
ORIGINAL RESEARCH
Published on 10 Dec 2024
ORIGINAL RESEARCH
Published on 25 Nov 2024
REVIEW
Published on 15 Nov 2024
ORIGINAL RESEARCH
Published on 07 Oct 2024
ORIGINAL RESEARCH
Published on 16 Sep 2024
REVIEW
Published on 21 Aug 2024
REVIEW
Published on 31 Jul 2024
ORIGINAL RESEARCH
Published on 10 May 2024
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: